Novo Nordisk stated that post hoc analyses of its CagriSema REDEFINE 1 trial are hypothesis-generating and require further study to confirm the results

552c7ae14Topic

Weight management

Supports users in reaching and maintaining a healthy body weight through behavioral and nutritional tools.

413 claims·67 news stories

0